Cancers, Vol. 16, Pages 1268: Racial Differences in the Detection Rate of Bladder Cancer Using Blue Light Cystoscopy: Insights from a Multicenter Registry

Cancers, Vol. 16, Pages 1268: Racial Differences in the Detection Rate of Bladder Cancer Using Blue Light Cystoscopy: Insights from a Multicenter Registry Cancers doi: 10.3390/cancers16071268 Authors: Seyedeh-Sanam Ladi-Seyedian Alireza Ghoreifi Badrinath Konety Kamal Pohar Jeffrey M. Holzbeierlein John Taylor Max Kates Brian Willard Jennifer M. Taylor Joseph C. Liao Hristos Z. Kaimakliotis Sima P. Porten Gary D. Steinberg Mark D. Tyson Yair Lotan Siamak Daneshmand the Blue Light Cystoscopy with Cysview Registry Group the Blue Light Cystoscopy with Cysview Registry Group The use of blue light cystoscopy (BLC) has been shown to improve bladder tumor detection. However, data demonstrating the efficacy of BLC across different races are limited. Herein, we aim to evaluate heterogeneity in the characteristics of BLC for the detection of malignant lesions among various races. Clinicopathologic information was collected from patients enrolled in the multi-institutional Cysview® registry (2014–2021) who underwent transurethral resection or biopsy of bladder tumors. Outcome variables included sensitivity and negative and positive predictive values of BLC and white light cystoscopy (WLC) for the detection of malignant lesions among various races. Overall, 2379 separate lesions/tumors were identified from 1292 patients, of whom 1095 (85%) were Caucasian, 96 (7%) were African American, 51 (4%) were Asian, and 50 (4%) were ...
Source: Cancers - Category: Cancer & Oncology Authors: Tags: Article Source Type: research